The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review.

Awan, Humza; Fatima, Urooj; Eaw, Ryan; Knox, Naomi; Alrubaiy, Laith

Awan, Humza; Fatima, Urooj; Eaw, Ryan; Knox, Naomi; Alrubaiy, Laith.

Afiliação

Awan H; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, GBR.
Fatima U; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, GBR.
Eaw R; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, GBR.
Knox N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, GBR.
Alrubaiy L; Gastroenterology, Swansea University Medical School, Swansea, GBR.

Cureus ; 15(4): e37609, 2023 Apr.

Article em En | MEDLINE | ID: mdl-37069838

Palavras-chave

adalimumab (humira); clinical trial & pharmacovigilance; golimumab; infliximab biosimilar; ulcerative colitis (uc); ustekinumab; vedolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Aspecto: Patient_preference Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google